Pancreatic cancer is the 12th most common cancer in the world and remains one of the deadliest, with a five-year survival rate of only 13%, despite recent progress.

Did you know that lung cancer is the most diagnosed cancer in the world? In 2022, it accounted for 12.4% of all new cancer cases and 18.7% of deaths. The 5-year survival rate for lung cancer has increased by 22% over the last 5 years due to advances in treatment. However, only 26% of cases are diagnosed at an early stage, when the survival rate is 61%.

Prostate cancer is on the increase globally, especially in men under the age of 50, and in 2022 there were 1.47 million new cases. The 5-year survival rate is close to 100%, largely thanks to advances in treatment and early detection.

Radiopharmaceutical therapy utilizes radioactive atoms to target and precisely treat cancer cells.

This case study looks at the challenges that arose in a Phase I First In Human trial for the progressive Wilson’s Disease

Cell & Gene Therapy: Safety and Clinical Activity in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma Case…

Rare Diseases: Phase II Pediatric Study with Selected Metabolic Disorders Case study Aixial Group is currently working on a Phase…

Data Science & Analytics: Combining A Phase I Study with an On-Going Observational Study Case study This case study looks…

Early Phase Oncology: First-In-Human Study Of An Antibody-Drug Conjugate In Breast Cancer Case study For a First In Human study,…

Early-Phase Oncology: First-In-Human Study in Advanced Solid Tumors Case study For a First In Human study, site activation and enrollment…

Rare Diseases: Phase II Primary Biliary Cholangitis Case study Rare disease research can be challenging and often there are no…

Efficient Publication Strategy Leads to Expedited Submission and Acceptance Case study Since the World Health Organization (WHO) launched the Global…